Vertex Pharmaceuticals (VRTX) Q3 2022 Earnings Report

6,831 Followers

VRTX Q3 2022 EPS Results

Actual EPS$4.01

Consensus EPS$3.61

Beat/MissBeat by +$0.40

One Year Ago EPS$3.56

Actual Revenue$2.27B

Expected Revenue$2.23B

Beat/MissBeat by +$39.08M

YoY Revenue Growth+14.06%

QuarterQ3 2022

Date10/27/2022

TimeAfter Close

Conference CallThursday, October 27, 2022

VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

VRTX Q3 2022 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 02, 2026	2026 (Q3)	4.76 / -	4.8	―
Aug 03, 2026	2026 (Q2)	4.74 / 4.73	4.52	4.65% (+0.21)
May 04, 2026	2026 (Q1)	4.24 / 4.47	4.06	10.10% (+0.41)
Feb 12, 2026	2025 (Q4)	5.11 / 5.03	3.98	26.38% (+1.05)
Nov 03, 2025	2025 (Q3)	4.57 / 4.80	4.38	9.59% (+0.42)
Aug 06, 2025	2025 (Q2)	4.29 / 4.52	-12.83	135.23% (+17.35)
May 05, 2025	2025 (Q1)	4.32 / 4.06	4.76	-14.71% (-0.70)
Feb 10, 2025	2024 (Q4)	4.02 / 3.98	4.2	-5.24% (-0.22)
Nov 04, 2024	2024 (Q3)	4.08 / 4.38	4.08	7.35% (+0.30)
Aug 01, 2024	2024 (Q2)	-11.63 / -12.83	3.89	-429.82% (-16.72)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed